Pathway to Commercialization

Kevin Nickels, a medical devices specialist from the Office for Technology Commercialization, draws from his own experiences to describe industry and regulatory hurdles that entrepreneurs may encounter on their path to commercialization.

Bob Schumacher, from the Center for Translational Medicine, presents key questions at all stages of the regulatory process, from validation and preclinical testing through FDA interactions and clinical trials to the marketplace.

Kirk Froggatt, from the Technological Leadership Institute, describes the commercialization process as crossing a "valley of death" between academia and the business world. Licensing, advising, and co-founding a company are discussed as options for pursuing your technology.